{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:38Z","timestamp":1761100958109,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2656,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bbmt.2007.09.013","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T18:16:17Z","timestamp":1196964977000},"page":"7-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Alemtuzumab-Induced Resolution of Refractory Cutaneous Chronic Graft-Versus-Host Disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Guillermo J.","family":"Ruiz-Arg\u00fcelles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Gil-Beristain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Maga\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo J.","family":"Ruiz-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.09.013_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2141.2007.06652.x","article-title":"The management and outcome of chronic graft-versus-host disease","volume":"138","author":"Fraser","year":"2007","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.bbmt.2007.09.013_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.beha.2006.11.004","article-title":"Novel strategies for the treatment and diagnosis of graft versus host disease","volume":"20","author":"Ferarra","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2007.09.013_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0190-9622(98)70495-5","article-title":"Graft-versus-host reactions in dermatology","volume":"38","author":"Johnson","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2007.09.013_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.bbmt.2006.08.043","article-title":"Cutaneous manifestations of chronic graft-versus-host disease","volume":"12","author":"Hymes","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 5","key":"10.1016\/j.bbmt.2007.09.013_bib5","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1053\/j.seminoncol.2006.01.028","article-title":"The role of alemtuzumab in nonmyeloablative hematopoietic transplantation","volume":"33","author":"Giralt","year":"2006","journal-title":"Sem Oncol"},{"key":"10.1016\/j.bbmt.2007.09.013_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.bmt.1704435","article-title":"Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decrease incidence of acute graft-versus-host disease with unique pharmacokinetics","volume":"33","author":"Khouri","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.013_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbmt.2005.05.010","article-title":"Treatment of severe refractory acute graft-versus-host disease of the gastrointestinal tract with Campath 1H","volume":"11","author":"Busca","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.013_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.bmt.1704322","article-title":"Alemtuzumab can successfully treat steroid-refractory acute graft versus host disease (aGVHD)","volume":"33","author":"Carella","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.013_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bmt.1704573","article-title":"Successful use of Campath-1H in the treatment of steroid refractory liver GVHD","volume":"34","author":"Wandroo","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.013_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1096-8652(199607)52:3<236::AID-AJH23>3.0.CO;2-C","article-title":"In vivo Campath-1 monoclonal antibodies: a novel mode of therapy for acute graft-versus-host disease","volume":"52","author":"Varadi","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2007.09.013_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0961203306075615","article-title":"Exploring new territory: considering the future","volume":"16","author":"Schneider","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.bbmt.2007.09.013_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bbmt.2007.02.007","article-title":"A single-center pilot validation study of a new chronic GVHD skin scoring system","volume":"13","author":"Greinix","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.013_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00128071-200405060-00005","article-title":"Dermatologic treatment of cutaneous graft versus host disease","volume":"5","author":"Pe\u00f1as","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.bbmt.2007.09.013_bib14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood-2002-01-0159","article-title":"Phase II trial of subcutaneous anti C52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)","volume":"100","author":"Lundin","year":"2002","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2007.09.013_bib15","first-page":"777","article-title":"Blood levels of alemtuzumab during treatment of patients with chronic lymphocytic leukemia: Comparison of intravenous and subcutaneous route of administration","volume":"100","author":"Hale","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.013_bib16","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood.V99.10.3554","article-title":"Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study","volume":"99","author":"Keating","year":"2002","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2007.09.013_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbmt.2006.12.299","article-title":"Alemtuzumab in the treatment of steroid refractory acute graft-versus-host disease","volume":"13","author":"G\u00f3mez-Almaguer","year":"2007","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107004880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107004880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:30:35Z","timestamp":1761057035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107004880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1083879107004880"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.09.013","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alemtuzumab-Induced Resolution of Refractory Cutaneous Chronic Graft-Versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}